Sustaglar Pen

Product details are provided by the manufacturer. Refer to the pack for complete information.

Diabetes mellitus (insulin therapy) to control high blood sugar when prescribed by a doctor.

Insulin is a hormone that helps glucose enter cells for energy and reduces glucose production by the liver. This lowers blood sugar levels and helps control diabetes-related symptoms and complications.

Use only as prescribed. This pen is for subcutaneous injection (under the skin) using a new needle each time; do not inject into a vein or muscle. Rotate injection sites (abdomen/thigh/upper arm). Follow dosing and timing advised by your doctor and monitor blood glucose regularly.

Hypoglycaemia (low blood sugar), injection site reactions (pain/redness/swelling), weight gain, itching or rash, lipodystrophy at injection site

Risk of hypoglycaemia—carry glucose/sugar and know symptoms (sweating, tremor, confusion). Do not share pen to avoid infection transmission. Use caution in kidney/liver impairment and during illness; dose adjustments may be needed. Do not stop or change dose without medical advice. Seek urgent care for severe allergy (swelling, breathing difficulty) or repeated severe low sugars.

Other antidiabetics, beta-blockers (may mask hypoglycaemia), corticosteroids, thiazide diuretics, thyroid hormones, sympathomimetics, MAO inhibitors, ACE inhibitors, alcohol (can increase hypoglycaemia risk)

Store unopened pen in refrigerator (2–8°C); do not freeze. Protect from light. After first use, store as per label (often at room temperature below 25–30°C) and discard after the in-use period; keep cap on when not in use.